SE8301725D0 - Substituerade 3,4-diamino-1,2,5-tiadiazoler med histamin-h?712-receptor-antagonistaktivitet - Google Patents

Substituerade 3,4-diamino-1,2,5-tiadiazoler med histamin-h?712-receptor-antagonistaktivitet

Info

Publication number
SE8301725D0
SE8301725D0 SE8301725A SE8301725A SE8301725D0 SE 8301725 D0 SE8301725 D0 SE 8301725D0 SE 8301725 A SE8301725 A SE 8301725A SE 8301725 A SE8301725 A SE 8301725A SE 8301725 D0 SE8301725 D0 SE 8301725D0
Authority
SE
Sweden
Prior art keywords
histamine
substituted
thiadiazoles
diamino
receptor antagonist
Prior art date
Application number
SE8301725A
Other languages
English (en)
Other versions
SE8301725L (sv
SE461040B (sv
Inventor
R R Crenshaw
A A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8301725D0 publication Critical patent/SE8301725D0/sv
Publication of SE8301725L publication Critical patent/SE8301725L/sv
Publication of SE461040B publication Critical patent/SE461040B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8301725A 1982-03-29 1983-03-28 Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav SE461040B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (3)

Publication Number Publication Date
SE8301725D0 true SE8301725D0 (sv) 1983-03-28
SE8301725L SE8301725L (sv) 1983-11-25
SE461040B SE461040B (sv) 1989-12-18

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8301725A SE461040B (sv) 1982-03-29 1983-03-28 Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav
SE8704689A SE464302B (sv) 1982-03-29 1987-11-25 Etandiimidamider som mellanprodukter foer framstaellning av histamin -h2-receptorantagonister och foerfarande foer framstaellning daerav

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8704689A SE464302B (sv) 1982-03-29 1987-11-25 Etandiimidamider som mellanprodukter foer framstaellning av histamin -h2-receptorantagonister och foerfarande foer framstaellning daerav

Country Status (30)

Country Link
JP (2) JPS58180477A (sv)
KR (1) KR880002209B1 (sv)
AT (1) AT386599B (sv)
AU (2) AU557577B2 (sv)
BE (1) BE896291A (sv)
CH (2) CH660880A5 (sv)
CS (2) CS250229B2 (sv)
DD (2) DD219768A5 (sv)
DE (1) DE3311281A1 (sv)
DK (2) DK166677B1 (sv)
ES (3) ES520982A0 (sv)
FR (2) FR2542741B1 (sv)
GB (2) GB2117769B (sv)
GR (1) GR78524B (sv)
HU (2) HU188742B (sv)
IE (1) IE55596B1 (sv)
IL (1) IL68259A0 (sv)
IT (1) IT1164633B (sv)
LU (1) LU84716A1 (sv)
MY (1) MY8700942A (sv)
NL (1) NL8301063A (sv)
NO (1) NO163055C (sv)
NZ (1) NZ203726A (sv)
OA (1) OA07356A (sv)
PT (1) PT76459B (sv)
SE (2) SE461040B (sv)
SU (2) SU1419518A3 (sv)
YU (1) YU44849B (sv)
ZA (1) ZA832154B (sv)
ZW (1) ZW7683A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
FI76795C (sv) * 1979-09-04 1988-12-12 Bristol Myers Co Förfarande för framställning av nya, terapeutiskt användbara 3,4-disub stituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanp rodukter
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
CH660880A5 (de) 1987-05-29
IE55596B1 (en) 1990-11-21
NO831100L (no) 1983-09-30
ZA832154B (en) 1983-12-28
SE8301725L (sv) 1983-11-25
SU1419518A3 (ru) 1988-08-23
JPH06135925A (ja) 1994-05-17
HU188742B (en) 1986-05-28
AU1290783A (en) 1983-10-06
KR840004095A (ko) 1984-10-06
CS250229B2 (en) 1987-04-16
YU44849B (en) 1991-04-30
NZ203726A (en) 1986-05-09
GB2117769B (en) 1985-08-29
DK81192A (da) 1992-06-18
IE830686L (en) 1983-09-29
DE3311281A1 (de) 1983-11-24
SU1355123A3 (ru) 1987-11-23
GB8432809D0 (en) 1985-02-06
CS250240B2 (en) 1987-04-16
SE8704689D0 (sv) 1987-11-25
DK141383A (da) 1983-09-30
GB2149406A (en) 1985-06-12
KR880002209B1 (ko) 1988-10-18
ES8505978A1 (es) 1985-06-16
CH655111A5 (de) 1986-03-27
BE896291A (fr) 1983-09-28
LU84716A1 (fr) 1983-12-05
AT386599B (de) 1988-09-12
DK166677B1 (da) 1993-06-28
DD210909A5 (de) 1984-06-27
JPS58180477A (ja) 1983-10-21
AU586037B2 (en) 1989-06-29
IT1164633B (it) 1987-04-15
DK81192D0 (da) 1992-06-18
PT76459A (en) 1983-04-01
FR2542741A1 (fr) 1984-09-21
OA07356A (fr) 1984-08-31
FR2597867A1 (fr) 1987-10-30
SE461040B (sv) 1989-12-18
ES8404683A1 (es) 1984-05-16
ES527686A0 (es) 1985-06-16
YU74483A (en) 1986-02-28
GR78524B (sv) 1984-09-27
AU557577B2 (en) 1986-12-24
GB8308518D0 (en) 1983-05-05
NO163055C (no) 1990-03-28
NO163055B (no) 1989-12-18
PT76459B (en) 1986-03-11
ATA111083A (de) 1988-02-15
FR2542741B1 (fr) 1989-12-08
SE464302B (sv) 1991-04-08
IT8348005A0 (it) 1983-03-28
JPH0568472B2 (sv) 1993-09-29
SE8704689L (sv) 1987-11-25
GB2149406B (en) 1986-01-02
ES8505977A1 (es) 1985-06-16
NL8301063A (nl) 1983-10-17
MY8700942A (en) 1987-12-31
ZW7683A1 (en) 1984-01-04
ES520982A0 (es) 1984-05-16
DD219768A5 (de) 1985-03-13
ES527685A0 (es) 1985-06-16
DK141383D0 (da) 1983-03-28
HU196386B (en) 1988-11-28
IL68259A0 (en) 1983-06-15
AU6327286A (en) 1987-01-08
GB2117769A (en) 1983-10-19
FR2597867B1 (fr) 1989-12-08

Similar Documents

Publication Publication Date Title
BG60249B2 (en) Thiazole compound for treatment of ulcers
NZ214005A (en) Benzimidazole derivatives and pharmaceutical compositions
FI924054A0 (fi) Iso- och heterocykliska foereningar kopplade med imidazol, foerfarande foer framstaellning av dessa och anvaendning av dessa.
FI845126A0 (fi) Nya pyridin-2-etrar och pyridin-2-tioetrar med en kvaevehaltig cykloalifatisk ring.
IT1209512B (it) Procedimento selettivo per il blocco di ricettori di 5ht2.
HUT56099A (en) Process for producing 2-(2-amino-thiazol-4-yl)-2-(4-pyridon-2-yl-methoxy-imino)-acetic acid derivatives
ES8505944A1 (es) Procedimiento para la preparacion de nuevas sulfonamidas.
ES8602721A1 (es) Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina.
SE8301725L (sv) Substituerade 3,4-diamino-1,2,5-tiadiazoler med histamin-h?712-receptor-antagonistaktivitet
ES8308326A1 (es) Procedimiento para la preparacion de amidobenzamidas.
DE60016786D1 (de) Bicyclische vasopressin-agoniste
CA1228067A (en) 3,4-DIAMINO-1,2,5-THIADIAZOLE SUBSTITUTION DERIVATIVES, ANTAGONISTS FOR H.SUB.2 HISTAMINE RECEPTORS
SE8503110L (sv) Substituerade 3,4-diamino-1,25-tiadiazoler med histamin-h?712-receptorantagonistaktivitet
MC1919A1 (fr) Derives de l'imidazole
SE8406338L (sv) 4,5,6,7-tetrahydrotiazolo/5,4-c/-pyridinderivat
ES8504750A1 (es) Un procedimiento para preparar compuestos heterociclicos
DK160093C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolderivater
ES509554A0 (es) "procedimiento para la preparacion de nuevas cefalosporinas".
SE8300580D0 (sv) Substituerade 1,3,4-tiadiazolo (3,2-a)pyrimidiner och forfarande for deras framstellning
SE321467B (sv)
ZA894399B (en) New derivatives of phenothiazine,their preparation and the compositions which contain them
PH18574A (en) Substituted 11-oxo-11h-pyrido 2,i-h -quinazoline derivatives,pharmaceutical compositions containing them and method of use thereof
GB1100419A (en) Substituted chlorosulphamyl-anthranilic acids
JPS5283850A (en) Heterocyclic compounds

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8301725-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8301725-1

Format of ref document f/p: F